This report aims to estimate the market size and future growth potential of the global market across different segments such as method, product, technology, application, end user, and region. Factors such as rising aging population, increase in product approvals and launches, growing number of sepsis cases, high incidence of bloodstream infections (BSI), increase in demand for rapid diagnostic techniques, and high prevalence of infectious diseases are driving the market growth. On the other hand, factors such as high cost of automated instruments and lack of technically skilled professionals may hinder the growth of blood culture test market.
The breakdown of the profiles of primaries is depicted in the figure below:
The global blood culture test market is projected to reach USD 4,768.9 Million by 2021 from USD 3, 252.6 Million in 2016, at a CAGR of 8.0% during the forecast period.
On the basis of product, the market is segmented into consumables, instruments, and software & services. In 2016, the consumables segment is estimated to account for the largest share of the market. The repeated purchase of consumables as compared to instruments is the major factor expected to drive the growth of this segment.
Based on application, the market is segmented into bacteremia, fungemia, and mycobacteria. Among these, bacteremia is estimated to account for the largest share of the market in 2016 and grow at the highest CAGR during the forecast period (2016-2021). The high growth rate and large share of this segment is primarily attributed to the increasing number of bloodstream infections and growing number of sepsis cases on a global level.
Blood Culture Test Market by Region
The global market is dominated by North America, followed by Europe. However, the market in Asia is expected to register the highest growth rate in the forecast period. Factors such as high incidence of sepsis and government initiatives to increase awareness on the disease, increasing demand for effective diagnostic techniques, rising awareness about early disease diagnosis, increasing adoption of advanced technologies, rapid rise in geriatric population, and growing regulatory approvals & availability of blood culture test products in this region are contributing to the high growth rate of this market segment.
Key players in the blood culture tests market include Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (U.S.), Cepheid, Inc. (U.S.), Nanosphere, Inc. (U.S.), Roche Diagnostics (Switzerland), Beckman Coulter (U.S.), Bruker Corporation (U.S.), IRIDICA (U.S.), and T2 Biosystems (U.S.).
Read More about Blood Culture Test Market:
https://www.marketsandmarkets.com/Market-Reports/blood-culture-test-market-159606753.html
